Related Experiment Video
Updated: Jan 22, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A
Pratima Dibba1, Andrew A Li2, George Cholankeril3
1Division of Gastroenterology, Women & Infants Hospital/Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
Abstract:
Nonalcoholic fatty liver disease (NAFLD) develops when the liver is unable to oxidize or export excess free fatty acids generated by adipose tissue lipolysis, de novo lipogenesis, or dietary intake. Although treatment has generally been centered on reversing metabolic risk factors that increase the likelihood of NAFLD by influencing lifestyle modifications, therapeutic modalities are being studied at the cellular and molecular level. The endocannabinoid system has been of recent focus. The agonism and antagonism of cannabinoid receptors play roles in biochemical mechanisms involved in the development or regression of NAFLD. Exocannabinoids and endocannabinoids, the ligands which bind cannabinoid receptors, have been studied in this regard. Exocannabinoids found in cannabis (marijuana) may have a therapeutic benefit. Our recent study demonstrated an inverse association between marijuana use and NAFLD among adults in the United States. This commentary combines knowledge on the role of the endocannabinoid system in the setting of NAFLD with the findings in our article to hypothesize different potential mechanisms that may influence the inverse relationship between cannabis and NAFLD.
Insights
Marijuana use shows an inverse association with nonalcoholic fatty liver disease (NAFLD). This suggests potential therapeutic benefits of cannabis in managing NAFLD, warranting further investigation into underlying mechanisms.
Area of Science:
- Hepatology
- Endocrinology
- Pharmacology
Background:
- Nonalcoholic fatty liver disease (NAFLD) arises from impaired fatty acid metabolism.
- Current NAFLD treatments focus on metabolic risk factors and lifestyle changes.
- The endocannabinoid system is increasingly recognized for its role in NAFLD pathogenesis.
Purpose of the Study:
- To explore the potential therapeutic role of cannabis in NAFLD.
- To investigate the inverse association between marijuana use and NAFLD.
- To hypothesize mechanisms linking the endocannabinoid system to NAFLD regression.
Main Methods:
- Analysis of an existing study on marijuana use and NAFLD in US adults.
- Review of scientific literature on the endocannabinoid system and NAFLD.
- Integration of findings to propose mechanistic hypotheses.
Main Results:
- A significant inverse association was observed between marijuana use and NAFLD prevalence.
- Cannabinoid receptor modulation impacts NAFLD development and regression.
- Exocannabinoids from cannabis may offer therapeutic benefits.
Conclusions:
- Cannabis (marijuana) use is inversely correlated with NAFLD.
- The endocannabinoid system presents a novel therapeutic target for NAFLD.
- Further research is needed to elucidate the specific mechanisms behind cannabis's effect on NAFLD.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Relationship Formation
Ending Relationships
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Inverse Hyperbolic Functions and Their Derivatives

